These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19412944)

  • 1. The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease.
    Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
    Mov Disord; 2009 Jul; 24(9):1325-32. PubMed ID: 19412944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of antidepressants in patients with Parkinson disease and depression.
    Menza M; Dobkin RD; Marin H; Mark MH; Gara M; Buyske S; Bienfait K; Dicke A
    Neurology; 2009 Mar; 72(10):886-92. PubMed ID: 19092112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management.
    Dobkin RD; Menza M; Bienfait KL; Gara M; Marin H; Mark MH; Dicke A; Friedman J
    Am J Geriatr Psychiatry; 2011 Mar; 19(3):222-9. PubMed ID: 20808132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease.
    Dobkin RD; Menza M; Bienfait KL; Gara M; Marin H; Mark MH; Dicke A; Tröster A
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):188-95. PubMed ID: 20463113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease.
    Moonen AJ; Wijers A; Leentjens AF; Christine CW; Factor SA; Juncos J; Lyness JM; Marsh L; Panisset M; Pfeiffer R; Rottenberg D; Serrano Ramos C; Shulman L; Singer C; Slevin J; McDonald W; Auinger P; Richard IH
    Parkinsonism Relat Disord; 2014 Jun; 20(6):644-6. PubMed ID: 24679737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants Trial in Parkinson's Disease (ADepT-PD): protocol for a randomised placebo-controlled trial on the effectiveness of escitalopram and nortriptyline on depressive symptoms in Parkinson's disease.
    Schrag A; Carroll C; Duncan G; Molloy S; Grover L; Hunter R; Brown R; Freemantle N; Whipps J; Serfaty MA; Lewis G
    BMC Neurol; 2022 Dec; 22(1):474. PubMed ID: 36510237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.
    Smith KM; Eyal E; Weintraub D;
    JAMA Neurol; 2015 Jan; 72(1):88-95. PubMed ID: 25420207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of recovery in depressed Parkinson's disease patients treated with paroxetine or venlafaxine.
    Broen MP; Leentjens AF; Köhler S; Kuijf ML; McDonald WM; Richard IH
    Parkinsonism Relat Disord; 2016 Feb; 23():80-5. PubMed ID: 26739248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance treatment for old-age depression preserves health-related quality of life: a randomized, controlled trial of paroxetine and interpersonal psychotherapy.
    Dombrovski AY; Lenze EJ; Dew MA; Mulsant BH; Pollock BG; Houck PR; Reynolds CF
    J Am Geriatr Soc; 2007 Sep; 55(9):1325-32. PubMed ID: 17767673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant therapy with antidepressants for the management of inflammatory bowel disease.
    Mikocka-Walus A; Prady SL; Pollok J; Esterman AJ; Gordon AL; Knowles S; Andrews JM
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012680. PubMed ID: 30977111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-depressive treatment in Parkinson's disease. A controlled trial of the effect of nortriptyline in patients with Parkinson's disease treated with L-DOPA.
    Andersen J; Aabro E; Gulmann N; Hjelmsted A; Pedersen HE
    Acta Neurol Scand; 1980 Oct; 62(4):210-9. PubMed ID: 7010875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.
    Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D
    Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate.
    Yeragani VK; Roose S; Mallavarapu M; Radhakrishna RK; Pesce V
    Neuropsychobiology; 2002; 46(3):125-35. PubMed ID: 12422059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy and safety of sertraline versus nortriptyline in major depression in patients 70 and older.
    Finkel SI; Richter EM; Clary CM
    Int Psychogeriatr; 1999 Mar; 11(1):85-99. PubMed ID: 10189602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL; Weisler RH; Chang W; Olausson B; Paulsson B; Brecher M; Agambaram V; Merideth C; Nordenhem A; Young AH;
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.
    Barrett JE; Williams JW; Oxman TE; Frank E; Katon W; Sullivan M; Hegel MT; Cornell JE; Sengupta AS
    J Fam Pract; 2001 May; 50(5):405-12. PubMed ID: 11350703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial.
    Sackeim HA; Haskett RF; Mulsant BH; Thase ME; Mann JJ; Pettinati HM; Greenberg RM; Crowe RR; Cooper TB; Prudic J
    JAMA; 2001 Mar; 285(10):1299-307. PubMed ID: 11255384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study.
    Wang Z; Tian J; Dai W; Zhang N; Wang J; Li Z
    Actas Esp Psiquiatr; 2024 Oct; 52(5):607-615. PubMed ID: 39403917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.